Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Should Value Investors Buy BNP Paribas (BNPQY) Stock?
Should Value Investors Buy BNP Paribas (BNPQY) Stock?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Is American Well (AMWL) Stock Outpacing Its Medical Peers This Year?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Is American Well (AMWL) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. American Well Corporation (AMWL) is a stock that can certainly grab the attention

Are Investors Undervaluing BorgWarner (BWA) Right Now?
Are Investors Undervaluing BorgWarner (BWA) Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Is Accel Entertainment (ACEL) Stock Outpacing Its Consumer Discretionary Peers This Year?
Is Accel Entertainment (ACEL) Stock Outpacing Its Consumer Discretionary Peers This Year?

For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Accel Entertainment (ACEL) one of those

Has Etsy (ETSY) Outpaced Other Retail-Wholesale Stocks This Year?Photo, wide shot, wide-angle lens,  Hotel, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d14bb504-852b-4d13-a69a-8cec9d4eb799.png
Has Etsy (ETSY) Outpaced Other Retail-Wholesale Stocks This Year?

For those looking to find strong Retail-Wholesale stocks, it is prudent to search for companies in the group that are outperforming their peers. Etsy (ETSY) is a stock that can certainly grab the

Why F.N.B. (FNB) is a Top Value Stock for the Long-Term
Why F.N.B. (FNB) is a Top Value Stock for the Long-Term

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Why Crocs (CROX) is a Top Value Stock for the Long-Term
Why Crocs (CROX) is a Top Value Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why Gap (GAP) is a Strong Value Stock
Here's Why Gap (GAP) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Northrop Grumman Secures a $225M Contract to Aid E-130J Program
Northrop Grumman Secures a $225M Contract to Aid E-130J Program

Northrop Grumman Corporation NOC recently secured a $225.1 million contract to design, develop and deliver training materials for the E-130J weapons systems training program. The contract was

Is This the Right Time to Retain IDXX Stock in Your Portfolio?
Is This the Right Time to Retain IDXX Stock in Your Portfolio?

IDEXX Laboratories, Inc.’s IDXX focus on innovation in CAG (Companion Animal Group) has resulted in a highly compelling portfolio of products and services for its commercial teams to support

Down 30.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Theravance Bio (TBPH)
Down 30.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Theravance Bio (TBPH)

Theravance Biopharma (TBPH) has been on a downward spiral lately with significant selling pressure. After declining 30.6% over the past four weeks, the stock looks well positioned for a trend

Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Patria Investments (PAX)
Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Patria Investments (PAX)

Patria Investments (PAX) has been on a downward spiral lately with significant selling pressure. After declining 10.3% over the past four weeks, the stock looks well positioned for a trend reversal

Advanced Drainage (WMS) Loses 12.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Advanced Drainage (WMS) Loses 12.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Advanced Drainage Systems (WMS) has been on a downward spiral lately with significant selling pressure. After declining 12.4% over the past four weeks, the stock looks well positioned for a trend

Monro (MNRO) Loses 6.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Monro (MNRO) Loses 6.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Monro Muffler Brake (MNRO) has been on a downward spiral lately with significant selling pressure. After declining 6.9% over the past four weeks, the stock looks well positioned for a trend reversal

Synopsys (SNPS) Recently Broke Out Above the 20-Day Moving Average
Synopsys (SNPS) Recently Broke Out Above the 20-Day Moving Average

Synopsys (SNPS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SNPS crossed above the 20-day moving average, suggesting a

Down 16.3% in 4 Weeks, Here's Why American Eagle (AEO) Looks Ripe for a Turnaround
Down 16.3% in 4 Weeks, Here's Why American Eagle (AEO) Looks Ripe for a Turnaround

American Eagle Outfitters (AEO) has been beaten down lately with too much selling pressure. While the stock has lost 16.3% over the past four weeks, there is light at the end of the tunnel as it is

AeroVironment Q3 Earnings Loom: What Should Investors Do Now?
AeroVironment Q3 Earnings Loom: What Should Investors Do Now?

AeroVironment AVAV is slated to release third-quarter fiscal 2026 results on March 10, 2026, after market close.The Zacks Consensus Estimate for revenues is pegged at $473 million, indicating an

Samsara Surges 12% as Q4 Earnings and Revenues Surpass Estimates
Samsara Surges 12% as Q4 Earnings and Revenues Surpass Estimates

Samsara Inc. IOT shares gained 11.5% during Thursday’s extended trading session after the company reported better-than-expected fourth-quarter fiscal 2026 results.

Samsara’s fourth-quarter non-GAAP

Company News for Mar 6, 2026
Company News for Mar 6, 2026
  • Canadian Natural Resources Limited’s CNQ shares rose 2.6% after it reported fourth-quarter 2025 earnings of 59 cents per share, beating the Zacks Consensus Estimate of 53 cents.
  • Shares of
Is It Worth Investing in Diversified Energy Company PLC (DEC) Based on Wall Street's Bullish Views?
Is It Worth Investing in Diversified Energy Company PLC (DEC) Based on Wall Street's Bullish Views?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Is It Worth Investing in Marvell (MRVL) Based on Wall Street's Bullish Views?
Is It Worth Investing in Marvell (MRVL) Based on Wall Street's Bullish Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Is Newmont (NEM) a Buy as Wall Street Analysts Look Optimistic?
Is Newmont (NEM) a Buy as Wall Street Analysts Look Optimistic?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Is It Worth Investing in Lam Research (LRCX) Based on Wall Street's Bullish Views?
Is It Worth Investing in Lam Research (LRCX) Based on Wall Street's Bullish Views?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Humacyte, Inc. (HUMA) Is Considered a Good Investment by Brokers: Is That True?
Humacyte, Inc. (HUMA) Is Considered a Good Investment by Brokers: Is That True?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Wall Street Analysts See Sea Limited (SE) as a Buy: Should You Invest?
Wall Street Analysts See Sea Limited (SE) as a Buy: Should You Invest?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm